ABEONA THERAPEUTICS INC. (ABEO) Free cash flow 2016–2025
ABEONA THERAPEUTICS INC. (ABEO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$84.3MFY2025 · since FY2016: -$13.5M → -$84.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$84.3M | -44.2% |
| FY2024 | -$58.5M | -56.6% |
| FY2023 | -$37.3M | +14.4% |
| FY2022 | -$43.6M | +37.5% |
| FY2021 | -$69.8M | -92.0% |
| FY2020 | -$36.4M | +47.4% |
| FY2019 | -$69.1M | -43.0% |
| FY2018 | -$48.4M | -105.6% |
| FY2017 | -$23.5M | -73.8% |
| FY2016 | -$13.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice